American College of Cardiology Collaborates with the Arkansas STEMI Advisory Council Working to Save Lives by Offering Early Heart Attack Care Educational Materials in Marshallese

The materials, which were previously only available in English and Spanish, provide this underserved, high-risk population with easily accessible information to help them recognize the early signs and symptoms of heart attacks, and know-how and when to seek care.

Heart disease is the number one killer of women and men worldwide; however, in many cases, heart disease, including heart attacks, are preventable.

“When a heart attack occurs, every second matters. The EHAC materials are important tools in educating Arkansans on the early signs of a heart attack and to dial 911 if they experience symptoms,” said Aravind Rao, MD, MPH, chair of the STAC. “We appreciate the ACC developing these tools to reach diverse populations in the state. By partnering with them, we will be able to reach our goal to improve heart attack care for the citizens of Arkansas.”

EHAC is a public awareness campaign to educate the public about the signs of an impending heart attack, including that heart attack symptoms can occur days or weeks before the actual event. By recognizing and treating heart attack symptoms early, patients can avoid potential damage caused by a full-blown heart attack. Early symptoms can include chest pressure, shortness of breath, weakness and others.

“Many people do not realize that, like cancer and diabetes, heart attacks have early signs and symptoms,” said Jenn Cash, ACC EHAC education outreach coordinator. “The ACC and the Arkansas STEMI Advisory Council share the same goal—to save more lives and reduce the mortality rate of cardiovascular disease. Creating and sharing these free materials with the Marshallese population in Arkansas allows us to expand our outreach at a critical time.”

Heart attack prevention is especially timely during the COVID-19 pandemic, as its been widely reported that heart attack patients are avoiding the ER due to fear of being exposed to the virus. The ACC, through its CardioSmart initiative, began an educational campaign in April to encourage patients to call 911 if they thought they were having a heart attack and to reassure them that proper protocols are in place to keep them safe in the emergency room.

Moving forward, the ACC and the STAC will continue their collaboration in making educational materials available and monitor cardiovascular trends within the NCDR Chest Pain MI Registry.

Marshallese EHAC materials will be available via free download and hospitals can request free printed materials. For more information visit healthy.arkansas.gov/programs-services/topics/stemi-advisory-council-stac or deputyheartattack.acc.org.

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”
Exit mobile version